STAAR Surgical Co
NASDAQ:STAA
STAAR Surgical Co
Capital Expenditures
STAAR Surgical Co
Capital Expenditures Peer Comparison
Competitive Capital Expenditures Analysis
Latest Figures & CAGR of Competitors
Company | Capital Expenditures | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
STAAR Surgical Co
NASDAQ:STAA
|
Capital Expenditures
-$20.5m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-42%
|
CAGR 10-Years
-19%
|
|
Cooper Companies Inc
NYSE:COO
|
Capital Expenditures
-$427.6m
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-7%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Capital Expenditures
-$144m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Capital Expenditures
-$177.7m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-25%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Capital Expenditures
-$119m
|
CAGR 3-Years
-113%
|
CAGR 5-Years
-33%
|
CAGR 10-Years
-37%
|
See Also
What is STAAR Surgical Co's Capital Expenditures?
Capital Expenditures
-20.5m
USD
Based on the financial report for Mar 29, 2024, STAAR Surgical Co's Capital Expenditures amounts to -20.5m USD.
What is STAAR Surgical Co's Capital Expenditures growth rate?
Capital Expenditures CAGR 10Y
-19%
Over the last year, the Capital Expenditures growth was -11%. The average annual Capital Expenditures growth rates for STAAR Surgical Co have been -35% over the past three years , -42% over the past five years , and -19% over the past ten years .